Tag

Medical Cannabis

All articles tagged with #medical cannabis

politics1 month ago•11 min saved

Illinois Expands Medical Cannabis Qualifying Conditions and Possession Rules

Illinois expanded its medical cannabis program by adding sickle cell disease and PMOS with chronic pain as qualifying conditions (bringing the total to 58). As part of SB 3222, adult‑use dispensaries can opt in to sell medical cannabis at the medical tax rate; adults may now possess up to 60 grams of flower, 10 grams of concentrates, and up to 1,000 mg of THC for medical patients. The law also doubles expungement eligibility for past convictions and tightens rules on hemp THC products. New qualifying conditions include female orgasmic disorder, endometriosis, ovarian cysts, and uterine fibroids, with Gov. Pritzker highlighting Illinois’ leadership on cannabis policy.

via Marijuana Moment|

#illinois #medical-cannabis #pmos

health-policy1 month ago•2 min saved

Illinois Expands Medical Cannabis Eligibility to Include PMOS and Sickle Cell Disease

IDPH adds polyendocrine metabolic ovarian syndrome (PMOS) with chronic pain and sickle cell disease to Illinois’ list of qualifying conditions for medical cannabis after review by the Medical Cannabis Advisory Board; the change, effective immediately, brings the total to 58 conditions and allows providers to certify patients right away.

via thexradio.com|

#health-policy #illinois #medical-cannabis

policy5 months ago•6 min saved

DEA Expands Federal Registration for Medical Cannabis Firms Ahead of Schedule III Move

DEA says it will roll out new registration forms for Medical Marijuana Manufacturer, Bulk Manufacturer, Analytical Lab, and Distributor to align with the DOJ’s phased move of marijuana from Schedule I to Schedule III. The current 60-day dispensary registration window ends June 26, and the new forms will be posted in coming weeks on the DEA Diversion Registration page. The applications will require details on licenses, security measures, ownership, suppliers, and access to controlled substances, and carry a nonrefundable $794 fee (PayPal now; other payment options to be added). The update is part of broader rescheduling actions, which include an expedited hearing process starting June 29; IRS guidance on taxes and ATF form updates are also anticipated as federal policy shifts on cannabis.

via Marijuana Moment|

#dea #marijuana-policy #medical-cannabis

politics5 months ago•17 min saved

Trump reclassifies state-licensed medical cannabis in landmark policy shift

President Trump reclassified state-licensed medical marijuana as a less-dangerous drug, marking a historic shift in how cannabis is treated at the federal level and signaling potential broader reforms, even as states continue to regulate medical cannabis.

via AP News|

#drug-scheduling #federal-policy #medical-cannabis

health6 months ago•2 min saved

New review finds cannabis medicines offer minimal relief for most mental health disorders

A Lancet-published review of 54 randomized trials (1980–2025, 2,477 participants) found cannabis-based medicines provide little to no benefit for most mental health and substance-use disorders such as anxiety, psychotic disorders, PTSD and opioid-use disorder; some limited benefits were seen for cannabis-use disorder withdrawal, Tourette’s tic severity, and certain autistic traits or insomnia, but overall the evidence quality is low and more high-quality trials are needed as medical cannabis use expands.

via Reuters|

#clinical-trials #health #lancet

politics9 months ago•3 min saved

Federal Reclassification of Marijuana Sparks State-Level Changes and Industry Impact

Tennessee lawmakers from both parties are calling for reform of state marijuana laws following the federal reclassification of cannabis to Schedule III, with Democrats advocating for medical use and decriminalization, while some Republicans remain opposed due to concerns about safety and efficacy.

via Tennessee Lookout|

#bipartisan-support #federal-government #marijuana-reform

politics9 months ago•2 min saved

Trump signs order to reclassify and expand access to marijuana

President Trump signed an executive order to reclassify marijuana from Schedule I to Schedule III, easing research restrictions and aligning it with certain prescription drugs, but stopping short of legalizing recreational use or changing criminal laws.

via The Guardian|

#federal-policy #marijuana #medical-cannabis

business9 months ago•21 min saved

Canopy Growth to Acquire MTL Cannabis, Strengthening Canada's Medical Cannabis Leadership

Canopy Growth is acquiring MTL Cannabis in a deal valued at approximately $125 million, aiming to strengthen its position as Canada's leading medical cannabis provider, expand its product portfolio, and increase capacity for international demand, with expected synergies of around $10 million annually.

via Canopy Growth|

#acquisition #business #canadian-market

world11 months ago•6 min saved

Federal Pay Halt and Rising U.S.-Colombia Tensions

The U.S. government shutdown is affecting federal workers' pay and potentially the food stamp program, while Colombia has withdrawn its ambassador from the U.S. amid deteriorating relations. Additionally, a major art theft occurred at the Louvre, and new European studies suggest medical cannabis may be effective for chronic back pain. Meanwhile, the popularity of pickleball has led to increased eye injuries, prompting calls for protective guidelines.

via NPR|

#federal-shutdown #louvre-heist #medical-cannabis

health1 year ago•1 min saved

Research Shows Cannabis as Effective Remedy for Insomnia

A study published in PLOS Mental Health found that cannabis-based medical products can improve sleep quality and reduce anxiety in insomnia patients over an 18-month period, with minimal side effects, suggesting potential as an alternative treatment where traditional options fail.

via ScienceDaily|

#cannabis #health #insomnia

health1 year ago•3 min saved

Majority of Medical Cannabis Patients Quit Within a Year

A study found that over half of patients using medical cannabis for chronic musculoskeletal pain stop within a year, with older age being the main predictor of discontinuation, raising questions about its long-term effectiveness.

via SciTechDaily|

#chronic-pain #discontinuation #health

health1 year ago•3 min saved

Cannabis Enhances Sleep and Reduces Anxiety in Insomnia Patients

A study published in PLOS suggests that cannabis-based medical products may improve sleep quality, reduce anxiety and depression, and alleviate pain in insomnia patients over an 18-month period, with mild side effects, though further controlled trials are needed to confirm safety and efficacy.

via Neuroscience News|

#anxiety #cannabis #health

health1 year ago•2 min saved

Record Rise in Marijuana Use Among Older Adults

Marijuana use among Americans aged 65 and older has increased significantly from 4.8% in 2021 to 7% in 2023, with higher usage among college-educated, higher-income, and female seniors, and a notable rise among those with multiple chronic diseases, especially in states where medical marijuana is legal.

via AARP|

#demographic-shifts #health #marijuana

world-news1 year ago•1 min saved

Japan Enforces Strict Cannabis Ban with New Legal Reforms

Japan has enacted revised laws criminalizing the use of cannabis and THC, with penalties including up to seven years in prison, amid rising drug abuse among young people. While possession and cultivation were already illegal, the new laws classify these substances as narcotics. The revisions also legalize medical cannabis products proven safe and effective, aligning with international practices. In 2023, cannabis-related investigations in Japan surpassed those for methamphetamine, with a significant portion involving individuals under 30.

via Kyodo News Plus|

#cannabis #drug-laws #japan

politics1 year ago•10 min saved

Nebraska Judge Supports Medical Cannabis Ballot Initiative

A Lancaster County District Court judge dismissed legal challenges against Nebraska's medical cannabis ballot petitions, allowing them to proceed to the 2024 general election. The lawsuit, led by former state senator John Kuehn and supported by the Nebraska Secretary of State and Attorney General, failed to invalidate enough petition signatures. Despite allegations of circulator fraud and improper notarizations, the court found insufficient evidence of widespread wrongdoing. The ruling is expected to be appealed to the Nebraska Supreme Court.

via Nebraska Examiner|

#ballot-measures #court-ruling #legal-challenge